APO RESEARCH · REPORT
Argatroban
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Product & engineering
Understand the product.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Selected research
Market Structure
Global Argatroban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
Read the full market overview
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
This report provides an overview of the global Argatroban market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Argatroban and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Argatroban sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Argatroban market size, projected growth trends, production technologies, key applications, and end-use industries.
Argatroban Segment by Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Argatroban Segment by Type
Argatroban Powder
Argatroban Injection
Argatroban Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Argatroban Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Argatroban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Argatroban and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Argatroban.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Argatroban market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Argatroban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Argatroban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Argatroban Powder
- Argatroban Injection
Applications
- Heparin-induced Thrombocytopenia (HIT)
- Percutaneous Coronary Intervention
- Cerebral Arterial Thrombosis
Companies covered
- Pfizer, Inc
- SANDOZ
- GlaxoSmithKline Plc
- fresenius-kabi
- Eagle Pharmaceuticals, Inc
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries Ltd
- WEST-WARD,INC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Argatroban Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Argatroban Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Argatroban Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Argatroban Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Argatroban Market Dynamics
- 2.1 Argatroban Industry Trends
- 2.2 Argatroban Industry Drivers
- 2.3 Argatroban Industry Opportunities and Challenges
- 2.4 Argatroban Industry Restraints
3 Argatroban Market by Manufacturers
- 3.1 Global Argatroban Revenue by Manufacturers (2021-2026)
- 3.2 Global Argatroban Sales by Manufacturers (2021-2026)
- 3.3 Global Argatroban Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Argatroban Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Argatroban Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Argatroban Manufacturers, Product Type & Application
- 3.7 Global Argatroban Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Argatroban Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Argatroban Players Market Share by Revenue in 2025
- 3.8.3 2025 Argatroban Tier 1, Tier 2, and Tier 3
4 Argatroban Market by Type
- 4.1 Argatroban Type Introduction
- 4.1.1 Argatroban Powder
- 4.1.2 Argatroban Injection
- 4.2 Global Argatroban Sales by Type
- 4.2.1 Global Argatroban Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Argatroban Sales by Type (2021-2032)
- 4.2.3 Global Argatroban Sales Market Share by Type (2021-2032)
- 4.3 Global Argatroban Revenue by Type
- 4.3.1 Global Argatroban Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Argatroban Revenue by Type (2021-2032)
- 4.3.3 Global Argatroban Revenue Market Share by Type (2021-2032)
5 Argatroban Market by Application
- 5.1 Argatroban Application Introduction
- 5.1.1 Heparin-induced Thrombocytopenia (HIT)
- 5.1.2 Percutaneous Coronary Intervention
- 5.1.3 Cerebral Arterial Thrombosis
- 5.2 Global Argatroban Sales by Application
- 5.2.1 Global Argatroban Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Argatroban Sales by Application (2021-2032)
- 5.2.3 Global Argatroban Sales Market Share by Application (2021-2032)
- 5.3 Global Argatroban Revenue by Application
- 5.3.1 Global Argatroban Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Argatroban Revenue by Application (2021-2032)
- 5.3.3 Global Argatroban Revenue Market Share by Application (2021-2032)
6 Global Argatroban Sales by Region
- 6.1 Global Argatroban Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Argatroban Sales by Region (2021-2032)
- 6.2.1 Global Argatroban Sales by Region (2021-2026)
- 6.2.2 Global Argatroban Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Argatroban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Argatroban Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Argatroban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Argatroban Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Argatroban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Argatroban Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Argatroban Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Argatroban Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Argatroban Revenue by Region
- 7.1 Global Argatroban Revenue by Region
- 7.1.1 Global Argatroban Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Argatroban Revenue by Region (2021-2026)
- 7.1.3 Global Argatroban Revenue by Region (2027-2032)
- 7.1.4 Global Argatroban Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Argatroban Revenue (2021-2032)
- 7.2.2 North America Argatroban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Argatroban Revenue (2021-2032)
- 7.3.2 Europe Argatroban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Argatroban Revenue (2021-2032)
- 7.4.2 Asia-Pacific Argatroban Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Argatroban Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Argatroban Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer, Inc
- 8.1.1 Pfizer, Inc Company Information
- 8.1.2 Pfizer, Inc Business Overview
- 8.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer, Inc Argatroban Product Portfolio
- 8.1.5 Pfizer, Inc Recent Developments
- 8.2 SANDOZ
- 8.2.1 SANDOZ Company Information
- 8.2.2 SANDOZ Business Overview
- 8.2.3 SANDOZ Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 SANDOZ Argatroban Product Portfolio
- 8.2.5 SANDOZ Recent Developments
- 8.3 GlaxoSmithKline Plc
- 8.3.1 GlaxoSmithKline Plc Company Information
- 8.3.2 GlaxoSmithKline Plc Business Overview
- 8.3.3 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GlaxoSmithKline Plc Argatroban Product Portfolio
- 8.3.5 GlaxoSmithKline Plc Recent Developments
- 8.4 fresenius-kabi
- 8.4.1 fresenius-kabi Company Information
- 8.4.2 fresenius-kabi Business Overview
- 8.4.3 fresenius-kabi Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 fresenius-kabi Argatroban Product Portfolio
- 8.4.5 fresenius-kabi Recent Developments
- 8.5 Eagle Pharmaceuticals, Inc
- 8.5.1 Eagle Pharmaceuticals, Inc Company Information
- 8.5.2 Eagle Pharmaceuticals, Inc Business Overview
- 8.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Portfolio
- 8.5.5 Eagle Pharmaceuticals, Inc Recent Developments
- 8.6 Mitsubishi Tanabe Pharma
- 8.6.1 Mitsubishi Tanabe Pharma Company Information
- 8.6.2 Mitsubishi Tanabe Pharma Business Overview
- 8.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Mitsubishi Tanabe Pharma Argatroban Product Portfolio
- 8.6.5 Mitsubishi Tanabe Pharma Recent Developments
- 8.7 Teva Pharmaceutical Industries Ltd
- 8.7.1 Teva Pharmaceutical Industries Ltd Company Information
- 8.7.2 Teva Pharmaceutical Industries Ltd Business Overview
- 8.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio
- 8.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 8.8 WEST-WARD,INC
- 8.8.1 WEST-WARD,INC Company Information
- 8.8.2 WEST-WARD,INC Business Overview
- 8.8.3 WEST-WARD,INC Argatroban Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 WEST-WARD,INC Argatroban Product Portfolio
- 8.8.5 WEST-WARD,INC Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Argatroban Value Chain Analysis
- 9.1.1 Argatroban Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Argatroban Production Mode & Process
- 9.2 Argatroban Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Argatroban Distributors
- 9.2.3 Argatroban Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst